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1. Introduction 
In recent times, different strategies for thermal ablation therapy have been in use. They 
include radiofrequency ablation, cryoablation therapy, laser ablation therapy, microwave 
ablation and high intensity focused ultrasound ablation, among others. Radiofrequency 
ablation (RFA) is used to destroy pathological tissue by inducing tissue necrosis through the 
heating of targeted tissue [1]. While ablation is currently used in the treatment of different 
diseases, tumour ablation is considered here, i.e. the treatment of cancerous tumours. Apart 
from RFA, thermal ablation therapy involves other strategies employed in the destruction of 
cancerous tumours. Cryoablation therapy (or cryotherapy) uses liquid nitrogen (or the 
expansion of argon gas) to freeze and kill abnormal tissue. After numbing the tissue around 
the mass, a cryoprobe, which is shaped like a large needle, is inserted into the middle of the 
lesion. An ice ball forms at the tip of the probe and continues to grow until the images 
confirm that the entire tumour has been engulfed, killing the tissue [2], [3]. The whole 
process involved in cryotherapy takes about 10 – 20 minutes to complete. The temperature 
and duration of freezing necessary to induce complete killing and necrosis are based on 
numerous in vivo and in vitro animal studies, some of which have been reviewed by Gage 
& Baust [4]. Generally, it has been accepted that a minimum freezing temperature of -40oC 
must be reached for at least 3 minutes for complete eradication of the tumour [5]. A rapid 
freeze followed by a slow thaw is the most damaging to cells, and a minimum of two freeze-
thaw cycles (freeze-thaw-freeze-thaw) was necessary for effective cryonecrosis to take place 
than a single cycle [6]. The cost of a cryoablation unit ranges upwards from $190,000, and 
each multi-use cryoprobe costs approximately $3,750 [7]. Laser Ablation (or interstitial laser 
photocoagulation) uses a highly concentrated beam of light to penetrate the cancerous tissue. 
The laser energy is emitted from an optical fibre placed within a needle positioned at the 
centre of the tumour using either stereotactic guidance or Magnetic Resonance Imaging 
(MRI) [8], [9]. Two methods for delivery of light have been described to produce larger 
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volumes of necrosis: multiple bare fibres in an array and cooled-tip diffuser fibres. The 
major drawback to this technique is its cost, requiring $30,000 to $75,000 for a portable, 
solid-state laser and $3,000 per set of multiple (50) user fibres [10]. Microwave ablation (MWA) 
or microwave coagulation uses microwave tissue coagulator for irradiation. Ultra-high 
frequency (2450 MHz) microwaves are emitted from a percutaneously placed microwave 
electrode inserted into the target tissue under ultrasonographic guidance. Microwave 
irradiation is carried out for about 60 seconds at a power setting of 60W per pulse. During 
irradiation, the ultrasonographic probe is placed adjacent to the microwave electrode to 
monitor the effectiveness of the tumour coagulation [11], [12]. A typical microwave 
generator costs approximately $65,000 [13].  High Intensity Focused Ultrasound (HIFU) ablation 
is a non-invasive treatment modality that induces complete coagulative necrosis of a deep 
tumour through the intact skin. HIFU uses sound energy to produce heat [14]-[16]. HIFU 
treatments are usually carried out in a single session, often as a day case procedure in the 
doctor’s office, with the patient either fully conscious, lightly sedated or under light general 
anaesthesia. One major advantage of HIFU over other thermal ablation techniques is that 
the transcutaneous insertion of probes into the target tissue is not necessary. The high 
powered focused beams employed in the procedure are generated from sources placed 
either outside the body (for treatment of tumours of the liver, kidney, breast, uterus, 
pancreas and bone) or in the rectum (for treatment of the prostate), and are designed to 
enable rapid heating of a target tissue volume, while leaving tissue in the ultrasound 
propagation path relatively unaffected [17]. Numerous extra-corporeal, transrectal and 
interstitial devices have been designed to optimise application-specific treatment delivery 
for HIFU procedures.  
This chapter focuses on the discussion of principles and application of the radiofrequency 
ablation therapy system as a minimally invasive treatment modality for hyperthermia 
therapy. Detailed work completed in the use of radiofrequency (RF) energy in cancer 
management by developing and testing an economical and effective thermal probe that will 
effectively destroy volumes of pathological tumours by means of hyperthermia is presented.  
2. Radiofrequency energy and the RF ablation system 
Basically, the term radio-frequency refers not to the emitted waves, but rather to the 
alternating electric current that oscillates in the high frequency range. Radiofrequency is a 
form of electromagnetic energy. This energy is formed from waves of electromagnetic 
energy moving together (or radiating) through space at the speed of light. Unlike ionizing 
radiation (e.g. gamma rays and x-rays), which affects the chemical makeup of cells and 
alters their genetic code, electromagnetic energy is non-ionizing. This means that it is not 
strong enough to ionize atoms and molecules in cells or alter their genetic makeup. 
Radiofrequency energy is safer than many cancer therapies because it is absorbed by living 
tissue as simple heat. Regardless of the heat source, cells die when they reach a certain 
temperature. The main tumoricidal effect of RF ablation occurs because the absorption of 
electromagnetic energy induces thermal injury to the tissue. But RF energy and the heat it 
generates does not alter the basic chemical structure of cells. A very important part of the RF 
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ablation system is the RF signal generator. This is where the energy deposited by the needle-
like active electrode is generated. The system comprises of a closed circuit consisting of a 
radiofrequency generator circuit, a power amplifier circuit, and the control circuit. A power 
supply circuit is also included to meet the power supply requirements of the system. The 
energy generated by the system is delivered to the tissue by the active electrode, whereas a 
dispersive electrode that acts as a patient plate provides a return part to complete the circuit. 
A simplified block diagram of the whole system is shown in figure 1 below.  
 
Figure 1. Block diagram of the RF ablation circuits 
2.1. Hyperthermic (thermal) coagulation necrosis 
Coagulation necrosis denotes “irreversible thermal damage to cells even if the ultimate 
manifestations of cell death do not fulfill the strict histological criteria of coagulative 
necrosis” [18]. The nature of the thermal damage caused by radiofrequency heating is 
dependent on both the tissue temperature achieved and the duration of heating. Here is 
what happens at various temperatures: 
 At 42oC, cells die but it may take a significant amount of time (approximately 60 min). 
 Between 42oC and 45oC, cells are more susceptible to damage by other agents like 
chemotherapy and radiation. 
 Over 46oC irreversible damage occurs depending on the duration of heating. 
 Between 50oC and 55oC, the duration necessary to shorten irreversible damage to cells is 
shortened to 4 – 6 minutes. 
 Between 50oC and 100oC there is near immediate coagulation of tissue, almost 
instantaneous protein denaturation, melting of lipid bilayers, irreversible damage to 
mitochondrial and cytosolic (key cellular) enzymes of the cells, DNA and RNA. 
 From 100oC to 110oC, tissue vaporizes and carbonizes, all of which decrease energy 
transmission and impede ablation. 
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Figure 2 shows tissue reaction to thermal injury at different temperatures [19]. For 
successful ablation, the tissue temperature should be maintained in the ideal range (50 – 
100oC) to ablate tumour adequately and avoid carbonization around the tip of the electrode 
due to excessive heating. For adequate destruction of tumour tissue, the entire volume of a 
lesion must be subjected to cytotoxic temperatures. Hence effective heating throughout the 
target volume (i.e. the tumour and about 5mm thickness around normal tissue) is required 
as shown in figure 3. Thus, the main objective of radiofrequency ablation therapy is to reach 
and maintain a temperature range of 50o – 100oC throughout the entire target volume for at 
least 4 – 6 minutes. However, the relatively slow thermal conduction from the electrode 
surface through the tissues increases the duration of application to 10 – 30 minutes. 
 
Figure 2. Tissue reaction to thermal injury at different temperatures 
 
Figure 3. Schematic diagram illustrating RF ablation 
Recommendations of heating for these extended durations are based on experimental and 
clinical data suggesting that thermal equilibrium and, hence, complete induction of 
coagulation are not achieved for a given radiofrequency application until these thresholds 
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are achieved. The development of a radiofrequency ablation system in this study is aimed at 
producing a device that is able to satisfy the minimum requirement for effective tumour 
ablation at the ideal (cytotoxic) ablation temperature. 
2.2. Principles of radiofrequency ablation  
Radiofrequency ablation is physically based on radiofrequency current (about 460 kHz) that 
passes through the target tissue from the tip of an active electrode (RF thermal probe) 
towards a dispersive electrode which serves as the grounding pad. These two electrodes are 
connected to a radiofrequency generator. The active electrode has a very small cross-
sectional area (a few square millimetres) with respect to the passive electrode. The active 
electrode is usually fashioned into the form of a needle-like probe that is inserted into the 
tumour. The dispersive electrode has a much larger area than the active electrode, on the 
order of 100cm2 or larger, and is usually placed firmly behind the right shoulder or the thigh 
of the subject, depending on the location of the tumour in the body. Current flowing into the 
dispersive electrode is the same as the current flowing into the active electrode. But since the 
active electrode has a far smaller cross-sectional area than the dispersive electrode, the 
current density in amperes per square meter (A/m2) is far greater. As a result of the 
difference in current density between the two electrodes, the energy at the tip of the probe 
leads to ionic agitation with subsequent conversion of friction into heat. The tissue ions are 
agitated as they attempt to follow the changes in direction of alternating electric current as 
shown in figure 4 below.  
 
Figure 4. Ionic agitation by alternating electric current 
The agitation results in frictional heat around the electrode. The marked discrepancy 
between the surface area of the needle electrode and the dispersive electrode causes the 
generated heat to be tightly focused and concentrated around the needle electrode. The use 
of a large grounding pad ensures maximum surface area for dispersion of current from the 
needle electrode. The grounding pad also maximizes dispersion of equal amounts of energy 
and heat at the grounding pad sites, thereby minimizes the risk of burns. The tissue 
underneath the passive electrode heats up only slightly, while the tissue in contact with the 
active electrode is resistively heated to elevated temperatures sufficient for tumour ablation 
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(coagulative necrosis). The strategy of RF ablation is to create a closed-loop circuit including 
the RF generator, the needle electrode, the patient (tissue) and the passive electrode 
(grounding pad) in series. The heating of tissue is due to the power dissipated in the tissue, 
which is found from the expression 
 2 dP VI  (1) 
where P is the power in watts (W),  is the resistivity of the tissue in Ohm-metres (-m), V is 
the tissue volume in cubic metres (m3), and Id is the current density in amperes per square 
metre (A/m2).  
Appreciable advances have been made over the past decade to produce application devices 
for RFA. The Radionics probe is an internally cooled device that also uses pulsing sequences 
to improve heating. It is available in one size (17Ga) and 10, 15, and 25cm lengths. It comes 
with a single electrode with a tip exposure of 2-4cm, or cluster electrode [20]. The RITA probe 
is a 15Ga device that comes with various arrays. It has a thermocouple at the tip of the probe 
that registers the tissue temperature, and that is used to monitor its effect. The LeVeen probe 
has multiple (36, 37) tines. There are 2.0, 3.0, 3.5 and 4.0cm diameter needles from which the 
tines are deployed. The LeVeen needle electrode is designed to deliver a consistent pattern 
of heat throughout the lesion [21]. These and other application devices for RFA are available 
for use in the USA and some parts of Europe. In spite of technical progress in the 
development of various application devices for radiofrequency ablation therapy, most 
patients with malignant tumours, especially in Sub-Saharan Africa, have not yet benefitted 
from this technology due to their limited availability and exhorbitant cost. A typical RF 
generator costs $25,000 and each single use probe costs approximately $800 to $1200 [22]. 
This paper presents the structure and experimental results of a low cost minimally invasive 
radiofrequency thermal probe developed for hyperthermia therapy. The probe developed is 
effective and economical, and represents more than 70% in cost reduction compared to 
commercially available reusable RF thermal probes reviewed.  
3. Materials and methods 
The RF thermal probe developed was designed on a SolidWorks platform and 
manufactured according to design specifications. The device consists of an RF shielded 
insulated handle with a needle probe. The shaft of the needle is also insulated except for the 
tip which makes physical contact with the tumour or volume to be treated. A coaxial cable 
connects the device to the RF power unit. The RF thermal probe uses a stainless steel needle 
(size 14G x 3-1/4) with a diameter and length of 2.1 x 80 mm, connected to the conducting 
coaxial cable in one end, and housed in an epoxy resin holder (probe handle) that is 120 mm 
long and 15 mm in diameter. The stainless steel needle is insulated, except for the exposed 
20 mm tip that makes direct contact with tissue. The insulation prevents normal tissue from 
being destroyed along with cancerous tissue during thermal ablation treatment. The probe 
(as shown in figure 5) is reusable and is made of epoxy-resin material that can be easily 
steam-cleaned.  
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An essential objective of radiofrequency ablation therapy is to achieve and maintain a 
temperature range of 50 – 100oC throughout the entire target volume for at least 4 – 6 
minutes [23-25]. From equation (1), power dissipated (P) is directly proportional to volume 
(V). Tumour is usually treated as a sphere, and volume of a sphere is given by, 
 3  (4 / 3)V r  (2) 
where r is the radius of the sphere. It follows that, power dissipated is directly proportional 
to the cube of the radius. The temperature rise follows the accepted cube root heating 
function. This means that the outer limit of critical cell temperature where cell necrosis takes 
place is reasonably well-defined by the applied power and will be spherical around a point 
source if the impedance remains constant. In practice, we have a short cylindrical contact 
volume in the tumour with non linear impedances. This results in an egg shaped volume 
being treated. 
 
Figure 5. RF thermal probe 
To verify that the radiofrequency thermal probe developed is a device that is able to satisfy 
this minimum requirement for effective tumour ablation at the ideal cytotoxic temperature, 
experimental tests were done with different tissues types to determine how each tissue type 
responds to RF energy by observing and recording the temperature change at the probe tip. 
Liver, lung, brain, kidney and soft tissue were tested at different power settings to 
determine which power setting gives the best results with each tissue type in terms of the 
minimum time to reach the ideal temperature range, and the maximum time to remain 
within this range without charring or vapourizing. An RF generator (460 KHz) was 
connected in a closed circuit with the RF thermal probe, tissue sample, and dispersive 
electrode in series. Each tissue type was tested with different power settings, and each test 
was done for about 15 minutes.  
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4. Results and discussion 
The extent of coagulation necrosis is dependent on the energy deposited, local tissue 
interaction minus the heat lost.  
        –   Coagulation necrosis energy deposited local tissue interactions heat loss   
Heat efficacy is defined as the difference between the amount of heat produced and the 
amount of heat lost. Therefore, effective ablation can be achieved by optimizing heat 
production and minimizing heat loss within the area to be ablated. The relationship 
between these factors has been well characterized as the “bio-heat equation.” Heat 
production is correlated with the intensity and duration of the radio-frequency energy 
deposited. Heat conduction or diffusion is usually explained as a factor of heat loss in 
regard to the electrode tip. Heat is lost mainly through convection by means of blood 
circulation. Therefore, the cooling tissue by perfusion can limit the reproducible size of 
the ablation lesion in vivo.  
Macroscopic and microscopic examination of tissue samples tested show clear evidence of 
coagulation necrosis. A tissue volume of up to 20 mm diameter was necrosed with the 
single-tine probe developed. The plots of temperature versus time for different tissue types 
tested using different power settings are presented in the following figures: 
 
Figure 6. Lung tissue results. 
From figure 6, it is seen that, while 1 watt was inadequate for coagulation necrosis in lung 
tissue, 3 watts showed evidence of carbonization, leading to a drop in temperature as 
further conduction is inhibited. The best result was achieved with 2 watts, which showed a 
steady rise in temperature maintained within the ideal ablation temperature range. 
The plot in figure 7 shows that, while 2 watts was below the ideal temperature range, and 
therefore inadequate for effective tissue necrosis, 4 watts was too high and showed 
evidence of carbonization, resulting in a drop in temperature due to inhibition in 
conduction. The best result in terms of effective tissue necrosis was achieved with the 3 
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Figure 7. Brain tissue results. 
 
Figure 8. Liver tissue results. 
In figure 8, the plot shows that, while 5 watts and 6 watts are within the ideal ablation zone, 
the 7 watts setting is too high for liver tissue as it produced carbonization resulting in 
temperature drop. The best result however was recorded with the 6 watts setting which 
shows a steady rise in temperature without carbonization or charring. 
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In figure 9, the results show that 15 watts produced temperature above the ideal ablation 
range, leading to carbonization and consequently a drop in temperature. Both 10 watts and 
13 watts are suitable for ablating kidney tissue as seen, with 13 watts giving the best results 
since it allows the use of a higher temperature. 
 
Figure 10. Soft tissue test results. 
In figure 10, the results show that, while 15 watts produced temperature within the ideal 
ablation range, the best result was obtained with the 20 watts power setting since the 
temperature is higher. This means that the ideal temperature range for treatment will be 
reached quicker with 20 watts. The 10 watts power setting produces temperature below the 
ideal range, and was therefore inadequate for ablating soft tissue. 
5. Summary of results 
The above results have been summarized in table 2 below showing the different tissue 
types, the best power settings suitable for each tissue type, the minimum and maximum 
time required to keep the temperature within the ideal ablation range of 50 to 1000C, and the 
total duration. The total duration is the difference between the maximum time and 
minimum time. 
 







Brain 3.0 4.30 15.0 10.30 
Kidney 13.0 1.30 15.0 13.30 
Liver 6.0 0.30 15.0 14.30 
Lung 2.0 2.30 15.0 12.30 
Soft tissue 20.0 1.30 15.0 13.30 
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6. Conclusion 
The search for less morbid and less invasive techniques for cancer treatment has led to a 
strong drive within the global oncology community to develop and implement even more 
minimally invasive diagnostic and therapeutic procedures. The goals of these minimally 
invasive therapies for the treatment of cancerous tumours that have made them attractive to 
both patients and physicians are summarized as:  
 Viable and effective treatment options and eradicate in situ local disease 
 They are minimally invasive and less traumatic 
 Real-time imaging guidance is possible 
 Most procedures require only local anaesthesia, and recovery time is faster 
 Procedure can be repeated in case of cancer recurrence  
 They are safer, with minimal side effects, and limit postoperative morbidities and 
mortality 
 Real-time imaging guidance is possible 
 Non-surgical candidates can benefit from these treatment modalities 
 They can be performed as an outpatient procedure, or with only a short hospital stay 
 Shorten the time to return to daily function and work, and  
 Their low-cost make them cheaper and ultimately reduce the overall cost of cancer 
treatment.  
With several ablation techniques available, the ablation characteristics and method of 
application will differentiate one ablation method from another. Though RF ablation is 
more widely used, it has its limitations. Most thermo-ablative procedures could be 
performed in the doctor’s office as an outpatient procedure with mild or no sedation. 
With RF ablation, it requires an increase in temperature to induce necrosis (tissue death). 
The heat needed for this necrosis requires that large amount of local anaesthetic be 
infused around the treatment site. This excess fluid blurs the ultrasound visualization of 
RFA and other heat-based ablation techniques. Though all the available literature agree 
that thermal ablation therapy is relatively safe and much less traumatic than radical 
surgical procedures, some complications and side effects have been reported. Some of 
these complications and side effects have been associated with probe design, probe 
placement, or the use of multiple probes. The use of both single and multiple probe 
placements have been described in many studies. Both have their advantages and 
disadvantages. Though multiple probes appear to be more successful in destroying larger 
tissue volumes, their use increases the risk of complications in the procedure. Finally, the 
high cost of RF ablation equipment, coupled with their limited availability has placed 
these treatment procedures above the reach of most patients and physicians in Sub-
Saharan Africa. This project work which aims to investigate the design and development 
of a minimally invasive thermo-active oncology probe, will narrow this price gap and make 
treatment more affordable, and readily available to the ordinary patient in Sub-Saharan 
Africa. 
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